ArticleJournal of clinical oncology : official journal of the American Society of Clinical Oncology2014

Is time to first skeletal-related event the best primary end point in the assessment of bisphosphonate efficacy in patients with castration-sensitive prostate cancer?

Francesca Valcamonico et al.PubMed ↗Publisher ↗

No numbers read from the abstract.